| Announce Date | 11/13/2025 |
| EPS Normalized Actual | $-0.38 (Beat by $0.11) |
| EPS GAAP Actual | $-0.38 (Beat by $0.11) |
| Revenue Actual | $0.668128B |
| Revenue Surprise | Beat by $668.128M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.11 |
| EPS GAAP Estimate | $-0.11 |
| Revenue Estimate | $0.0051B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2025 | 0 | INF | 0 | 0 | 0 |
| Dec 2024 | -0.5 | -2.28 | -0.5 | -0.5 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.38 | -0.32 | 0.668128B | 62.04% | 664.63M |
| FQ2 2025 (Jun 2025) | -0.66 | -0.66 | 0.00057923B | -53191.78% | -2.92M |
| FQ1 2025 (Mar 2025) | -1188.69 | -1188.69 | 0.454501B | 99.92% | 451.8M |
| FQ4 2024 (Dec 2024) | -1.22 | -1.12 | 0.000690688B | 10.85% | -0.21M |
| FQ3 2024 (Sep 2024) | -990.72 | -990.57 | 0.253599B | 99.91% | 252.7M |
| FQ2 2024 (Jun 2024) | -1.87 | -1.87 | 0.308682B | 100% | 308.68M |
| FQ1 2020 (Mar 2020) | -0.0969 | -0.0969 | 8.973E-6B | 100% | 0.01M |
| FQ2 2020 (Jun 2020) | -0.0969 | -0.0969 | 8.973E-6B | 100% | 0.01M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.11
Consensus Revenue Estimates
0.0051B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.13 | -- | 0.13 | 0.13 | 1 |
| FQ3 2026 (Sep 2026) | 0.36 | 205.56 | 0.36 | 0.36 | 1 |
| FQ2 2026 (Jun 2026) | 0.07 | 1042.86 | 0.07 | 0.07 | 1 |
| FQ1 2026 (Mar 2026) | -0.11 | -1080527.27 | -0.11 | -0.11 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
| FQ3 2026 (Sep 2026) | 0.01B | -9179.56 | 0.01B | 0.01B | 1 |
| FQ2 2026 (Jun 2026) | 0.01B | 90.18 | 0.01B | 0.01B | 1 |
| FQ1 2026 (Mar 2026) | 0.01B | -8811.78 | 0.01B | 0.01B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.06 | -0.38 | -0.32 | 84.21% |
| FQ2 2025 (Jun 2025) | 0 | -0.66 | -0.66 | 100% |
| FQ1 2025 (Mar 2025) | 0 | -1188.69 | -1188.69 | 100% |
| FQ4 2024 (Dec 2024) | -0.1 | -1.22 | -1.12 | 91.8% |
| FQ3 2024 (Sep 2024) | -0.15 | -990.72 | -990.57 | 99.98% |
| FQ2 2024 (Jun 2024) | -1.87 | -1.87 | 100% | |
| FQ1 2020 (Mar 2020) | -0.0969 | -0.0969 | 100% | |
| FQ2 2020 (Jun 2020) | -0.0969 | -0.0969 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.67B | $664.63M | 99.48% |
| FQ2 2025 (Jun 2025) | $0B | $0B | $-2.92M | -504.25% |
| FQ1 2025 (Mar 2025) | $0B | $0.45B | $451.8M | 99.41% |
| FQ4 2024 (Dec 2024) | $0B | $0B | $-0.21M | -30.3% |
| FQ3 2024 (Sep 2024) | $0B | $0.25B | $252.7M | 99.65% |
| FQ2 2024 (Jun 2024) | $0B | $0.31B | $308.68M | 100% |
| FQ1 2020 (Mar 2020) | $0B | $0B | $0.01M | 100% |
| FQ2 2020 (Jun 2020) | $0B | $0B | $0.01M | 100% |